Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: Effect on cell cycle and cyclin expression

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 349-357

  Kronemann, Nicola ^a,b   Nockher, Wolfgang A ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

8 Br cyclic AMP; 8 Br cyclic GMP; Cell cycle; Cyclins; Forskolin; Nitric oxide donor; Proliferation; Sodium nitroprusside; VSMC

Indexed keywords

8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; CYCLIC AMP; CYCLIC GMP; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; FORSKOLIN; MESSENGER RNA; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG EFFECT; FETAL CALF SERUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL COUNT; CELL CYCLE; CELL DIVISION; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; CYCLIC AMP; CYCLIC GMP; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLINS; FORSKOLIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; MALE; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; RATS; RATS, WISTAR; RNA, MESSENGER; VASODILATOR AGENTS;

EID: 0032893385     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702305     Document Type: Article

References (42)

1. ABELL, T.J., RICHARDS, A.M., IKRAM, H., ESPINIER, E.A. & YANDLE, T. (1989). Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by plateletderived growth factor. Bioclicm. Biophys. Res. Commun.. 160, 1392-1396.
2. ABSENDER, J.W., SOUTHGATE, K.M., HALLETT, M.B. & NEWBY, A.C. (1992). Inhibition of proliferation, but not of Ca2 + mobilization, by cyclic AMP and GMP in rabbit aortic smooth muscle cells. Biochem. J., 288, 527-532.
3. BARLAT, I., HENGLEIN, B., PLET, A., LAMB, N., FERNANDEZ, A.,
4. MCKENZIE, F., POUYSSéGUR, j., VIE, A. & BLANCHARD, J.M. . (1995). TGF-, and cyclic AMP attenuate cyclin A gene transcription via a cyclic AMP responsive element through independent pathways. Oncogene, II, 1309-1318.
5. BEAVO, J.A. & REIFSYNDER, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sei., 11, 150-155.
6. BUSSE, R. & FLEMING, I. (1996). Endothelial dysfunction in atherosclerosis. J. Vase. Res., 331, 181 -194.
7. CAYATTE, A.J., PALACINO, J.J., HORTEN, K. & COHEN, R.A. (1994). Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arteriosclerosis Thromb., 14, 753-759.
8. COOKE, J.P., SINGER, A.M., TSAO, P., ZERA, P., ROWAN, R.A. & BILLINGHAM, M.E. (1992). Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest., 90, 11681172.
9. CORNWELL, T.L., ARNOLD, E., BOERTH, N.J. & LINCOLN, T.M. (1994). Inhibition of smooth muscle cell growth by nitric oxide and activation of cyclic AMP-dependent protein kinase by cGMP. Am. J. Physiol., 267, C1405-C1413.
10. DESDOUETS, C, MATESIC, G., MOL1NA, C.A., FOULKES, N.S., SASSONE-CORSI, P., BRÉCHOT, C. & SOBCZAK-THÉPOT, J. (1995). Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol. Cell. Biol.. 15, 3301-3309.
11. FORTE, L.R., THORNE, P.K., EBER, S.L., KRAUSE, W.J., FREEMAN, R.H., FRANCIS, S.H. & CORBIN, J.D. (1992). Stimulation of intestinal Cl- transport by heat-stable enterotoxin: activation of cyclic AMP-dependent protein kinase by cGMP. Am. J. Physiol., 263, C607-C615.
12. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1989). Endotheliumderived relaxing and contracting factors. FASEB J., 3, 20072018.
13. GAGELIN, C., PIERRE, M. & TORU-DELBAUFFE, D. (1994). . Inhibition of Gl cyclin expression and Gl cyclin-dependent protein kinases by cyclin AMP in an astrocytic cell line. Biochem. Biophys. Res. Commun., 205, 923-929.
14. GARG, U.C. & HASSID, A. (1989). Nitric oxide-generating vasodilators and 8-Br-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest., 83, 1774-1777.
15. GARG, U.C. & HASSID, A. (1993). Mechanisms of nitrosothiolinduced antimitogenesis in rat aortic smooth muscle cells. Ear. J. Pharmacol., 237, 243-249.
16. GROVES, P.M., BANNING, A.P., PENNY, W.J., NEWBY, A.C., CHEADLE, H.A. & LEWIS, M.J. (1995). The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc. Res., 30, 87-96.
17. GRUETTER, C.A., GRUETTER, D.Y., LYON, J.E., KADOWTIZ, P.J. & IGNARRO, L.I. (1981). Relationship between cyclic guanosine 3 1:5 1-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of méthylène blue and methemoglobin. J. Pharmacol. Exp. Ther.. 219, 181-186.
18. GUO, J.-P., MILHOAN, K.A., TUAN, R.S. &. LEFER, A.M. (1994). Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor in rat carotid artery intimai injury. Circ. Res., 75, 77-84.
19. GUO, K., ANDRES, V. & WALSH, K. (1998). Nitric oxide-induced downregulation of cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. Circulation. 97, 2066-2072.
20. HERBER, B., TRUSS, M., BEATO, M. & MÜLLER, R. (1994). Inducible regulatory elements in the human cyclin Dl promoter. Oncogcne, 9, 1295-1304.
21. ISHIDA, A., SASAGURI, T., KOSAKA, C., NOJIMA, H. & OGATA, J. (1997). Induction of the cyclin dependent kinase inhibitor p2jSdii/ciPi/waiï jjy nitric oxide-generating vasodilator in vascular smooth muscle cells. J. Biol. Chem., 272, 10050-10057.
22. JONZON, B., NILSSON, J. & FREDHOLM, B.B. (1985). Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J. Cell. Physiol., 124,451-456.
23. KARIYA, K., KAWAHARA, Y., ARAKI, S., FUKUZAKI, H. & TAKAI, Y. (1989). Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis, 30, 143-147.
24. KOFF, A., CROSS, F., FISHER, A., SCHUMACHER, J., LEGUELLEC, K., PHLIPPE, M. & ROBERTS, J.M. (1991). Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 66, 1217-1228.
25. KULLO, I.J., SCHWARTZ, R.S., POMPILI, V.J., TSUTSUI, M., MILSTIEN, S., FITZPATRICK, L.A., KATUSIC, Z.S. & O 1BRIEN, T. (1997). Expression and function of recombinant endothelial nitric oxide synthase in coronary artery smooth muscle cells. Arlerioscler. Tliromb & Vase. Biol., 17, 2405-2412.
26. KWON, N.S., STUEHR, D.J., & NATHAN, C.F. (1991). Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Met!., 174, 761-767.
27. L 1ALLEMAIN, G., LAVOIE, J.N., RIVARD, N., BALDIN, V. & POUYSSÉGUR, J. (1997). Cyclin Dl is a major target of the cyclic AMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene, 14, 1981-1990.
28. LEITMAN, D.C., FISCUS, R.R. & MURAD, F. (1986). Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells. J. Cell. Physiol., 127,237 -243.
29. LOESBERG, C, VAN WIJK, R., ZANDBERGEN, J., VAN AREN, W.G., VAN MOURIR, J.A. & DE GROOT, P.H.G. (1985). Cell cycledependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin El. Exp. Cell. Res., 160, 117- 125.
30. MARKS, D.S., VITA, J.A., FOLTS, J.D., KEANEY, J.F., JR., WELCH, G.N. & LOSCALZO, J. (1995). Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest., 96, 2630-2638.
31. MCNAMARA, D.B., BEDI, B., AURORA, H., TENA, L., IGNARRO, L.J., KADOWITZ, P.J. & AKERS, D.L. (1993). L-arginine inhibits balloon catheter-induced intimai hyperplasia. Biochem. Biophys. Res. Commun., 193, 291-296.
32. MOORADIAN, D.L., HUTSELL, T.C. & KEEPER, L.K. (1995). Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. PharmacoL, 25, 674-678.
33. PINES, J. (1995). Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J.. 308, 697-711.
34. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2, 1057-1058.
35. SARKAR, R., GORDON, D., STANLEY, J.C. & WEBB, C. (1997). Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells. J. Hyperlens., 15, 275-283.
36. SCOTT-BURDEN, T., SCHINI, V.B., ELIZONDO, E., JUNQUERO, D.C. & VANHOUTTE, P.M. (1992). Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokineinduced production of nitric oxide by cultured smooth muscle cells. Ore. Res., 71, 1088-1100.
37. SCOTT-BURDEN, T. & VANHOUTTE, P.M. (1993). The endothelium as a regulator of vascular smooth muscle proliferation. Circulation, 87, V51-V55.
38. TAKAGI, K., ISOBE, Y., YASUKAWA, K., OKOUCHI, E & SUKETA, Y. (1994). Nitric oxide blocks the cell cycle of mouse macrophagelike cells in the early G2 + M phase. FEBS Letts, 340, 159-162.
39. THE ACCORD STUDY INVESTIGATORS. (1997). Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographie restenosis after coronary balloon angioplasty. The ACCORD Study. Circulation, 95, 83-89.
40. VON DER LEYEN, H.E., GIBBONS, G.H., MORISHITA, R., LEWIS, N.P., ZWANG, L., NAKAJIMA, M., KANEDA, Y., COOKE, J.P. & DZAU, V.J. (1995). Gene therapy inhibiting neointimal hyperplasia: in vivo transfer of endothelial nitric oxide synthase gene. Proc. Nail. Acad. Sei. U.S.A.. 92, 1137-1141.
41. WEI, G.L., KRASINSKI, K., KEARNEY, M., ISNER, J.M., WALSH, K. & ANDRES, V. (1997). Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ. Res., 80, 418-426.
42. YU, S.M., CHENG, Z.G., GUH, J.H. & KUO, S.C. (1995). Mechanism of antiproliferation caused by YC-I, an indazole derivative, in cultured rat A10 vascular smooth muscle cells. Biochem. J., 306, 787-792.